(RTTNews) - After ending the previous session mostly lower, stocks may move back to the upside in early trading on Friday. The major index futures are currently pointing to a higher open for the markets, with the S&P 500 futures up by 0.4 percent.
(RTTNews) - After ending the previous session mostly lower, stocks may move back to the upside in early trading on Friday. The major index futures are currently pointing to a higher open for the markets, with the S&P 500 futures up by 0.4 percent.
FirstCash ( FCFS ) declares $0.42/share quarterly dividend , in line with previous. Forward yield 0.79% Payable May 30; for shareholders of record May 15; ex-div May 15. See FCFS Dividend Scorecard, Yield Chart, & Dividend Growth. More on FirstCash FirstCash: Strong Business Prospects, But Current Valuation Limits Margin Of Safety FirstCash Non-GAAP EPS of $2.69 beats by $0.30, revenue of $1.05B b...
FirstCash ( FCFS ) declares $0.42/share quarterly dividend , in line with previous. Forward yield 0.79% Payable May 30; for shareholders of record May 15; ex-div May 15. See FCFS Dividend Scorecard, Yield Chart, & Dividend Growth. More on FirstCash FirstCash: Strong Business Prospects, But Current Valuation Limits Margin Of Safety FirstCash Non-GAAP EPS of $2.69 beats by $0.30, revenue of $1.05B beats by $40M FirstCash Q1 2026 Earnings Preview Seeking Alpha’s Quant Rating on FirstCash Historical earnings data for FirstCash
Applied Digital (NASDAQ: APLD) is building a serious AI infrastructure story, but the market is forcing investors to confront the gap between explosive growth and real execution risk. That tension is what could decide whether this recent pullback becomes a major opportunity or a
Applied Digital (NASDAQ: APLD) is building a serious AI infrastructure story, but the market is forcing investors to confront the gap between explosive growth and real execution risk. That tension is what could decide whether this recent pullback becomes a major opportunity or a
Anna Moneymaker/Getty Images News President Donald Trump, who has been urged by Republicans to drop U.S. prosecutors' investigation into Federal Reserve Chair Jerome Powell, indicated he may be open to an alternate probe, according to a media report on Friday. When a Semafor reporter asked him if someone outside the U.S. Justice Department could get the answers he's seeking, Trump said, "[They] co...
Anna Moneymaker/Getty Images News President Donald Trump, who has been urged by Republicans to drop U.S. prosecutors' investigation into Federal Reserve Chair Jerome Powell, indicated he may be open to an alternate probe, according to a media report on Friday. When a Semafor reporter asked him if someone outside the U.S. Justice Department could get the answers he's seeking, Trump said, "[They] could. I mean, look, it's pretty easy." GOP senators and Treasury Secretary Scott Bessent have suggested congressional investigations could serve the same purpose as the DOJ probe and would then allow the Senate vote on Fed chair nominee Kevin Warsh to proceed. Sen. Thom Tillis (R-NC) vows to block a confirmation vote on any Fed chair nominee until the Justice Department probe ends. The investigation centers on major cost overruns at the Fed's multibillion-dollar renovation and whether Powell lied to Congress about the project. Several Republican senators have stated that his testimony didn't constitute a crime. Powell and many others see the investigation as a pretext to pressure the Fed to lower rates. In response to a different question, Trump said, "You have to find out what went wrong," Semafor reported. "It was beautiful, and they ripped it down, and probably because it cost so much to fix it." The president also took the opportunity to take another swipe at Powell over monetary policy. "On top of that, he's been terrible on interest rates," he said, according to the report . Dear readers: We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion. More on the Federal Reserve The Fed Preview - Brace For Hikes, Inflation Is Likely Persistent Warsh confirmation expected despite questions on holdings, Fed Independence Fed chair nominee seeks policy reforms, new framework, new communications
Alistair Berg Stock index futures surged on Friday as the ceasefire between Israel and Lebanon got extended by three weeks. Here are four stocks to keep an eye on: AbbVie ( ABBV ) shares fell 0.40% in early action after the U.S. Food and Drug Administration has declined to approve TrenibotE (trenibotulinumtoxinE), an anti-wrinkle therapy developed by the AbbVie unit, Allergan Aesthetics. In a stat...
Alistair Berg Stock index futures surged on Friday as the ceasefire between Israel and Lebanon got extended by three weeks. Here are four stocks to keep an eye on: AbbVie ( ABBV ) shares fell 0.40% in early action after the U.S. Food and Drug Administration has declined to approve TrenibotE (trenibotulinumtoxinE), an anti-wrinkle therapy developed by the AbbVie unit, Allergan Aesthetics. In a statement late Thursday, AbbVie announced that the FDA issued a complete response letter in response to its Biologics License Application for TrenibotE, a botulinum neurotoxin with a rapid onset of action and a short duration of effect. Procter & Gamble ( PG ) shares rose +3.4% before the bell on Friday after the household products giant showed solid results across its key segments with its FQ3 earnings report. "We delivered a solid acceleration in top-line results in our fiscal third quarter, with broad-based growth across product categories and regions," noted CEO Shailesh Jejurikar. Organic sales were up 3% to beat the consensus estimate for a gain of 2.8%. Volume was up 2% during the quarter, while pricing was 1% higher. Eli Lilly ( LLY ) shares fell 1.84% in premarket trading after Bloomberg reported that weekly prescriptions for the company’s weight loss therapies, Foundayo and Zepbound, trailed those for Novo Nordisk ’s rival drug , Wegovy, according to IQVIA data sourced by analysts. Cantor analyst Carter Gould noted that total prescriptions for Zepbound for the week ending April 17 fell ~2% from the prior week, while those for Novo’s Wegovy injectable rose 7% for the same week. Microsoft ( MSFT ) shares rose +1.11% ahead of the open as the company is offering voluntary buyouts to a portion of its U.S. workforce—marking a first for the 51-year-old software giant—as the tech industry navigates significant shifts driven by the rise of artificial intelligence. According to an internal memo obtained by CNBC and Bloomberg, the company extended buyout offers to roughly 7% of ...
Alistair Berg Stock index futures surged on Friday as the ceasefire between Israel and Lebanon got extended by three weeks. Here are four stocks to keep an eye on: AbbVie ( ABBV ) shares fell 0.40% in early action after the U.S. Food and Drug Administration has declined to approve TrenibotE (trenibotulinumtoxinE), an anti-wrinkle therapy developed by the AbbVie unit, Allergan Aesthetics. In a stat...
Alistair Berg Stock index futures surged on Friday as the ceasefire between Israel and Lebanon got extended by three weeks. Here are four stocks to keep an eye on: AbbVie ( ABBV ) shares fell 0.40% in early action after the U.S. Food and Drug Administration has declined to approve TrenibotE (trenibotulinumtoxinE), an anti-wrinkle therapy developed by the AbbVie unit, Allergan Aesthetics. In a statement late Thursday, AbbVie announced that the FDA issued a complete response letter in response to its Biologics License Application for TrenibotE, a botulinum neurotoxin with a rapid onset of action and a short duration of effect. Procter & Gamble ( PG ) shares rose +3.4% before the bell on Friday after the household products giant showed solid results across its key segments with its FQ3 earnings report. "We delivered a solid acceleration in top-line results in our fiscal third quarter, with broad-based growth across product categories and regions," noted CEO Shailesh Jejurikar. Organic sales were up 3% to beat the consensus estimate for a gain of 2.8%. Volume was up 2% during the quarter, while pricing was 1% higher. Eli Lilly ( LLY ) shares fell 1.84% in premarket trading after Bloomberg reported that weekly prescriptions for the company’s weight loss therapies, Foundayo and Zepbound, trailed those for Novo Nordisk ’s rival drug , Wegovy, according to IQVIA data sourced by analysts. Cantor analyst Carter Gould noted that total prescriptions for Zepbound for the week ending April 17 fell ~2% from the prior week, while those for Novo’s Wegovy injectable rose 7% for the same week. Microsoft ( MSFT ) shares rose +1.11% ahead of the open as the company is offering voluntary buyouts to a portion of its U.S. workforce—marking a first for the 51-year-old software giant—as the tech industry navigates significant shifts driven by the rise of artificial intelligence. According to an internal memo obtained by CNBC and Bloomberg, the company extended buyout offers to roughly 7% of ...
(RTTNews) - Canadian stocks are likely to open on a mixed note Friday morning with investors making cautious moves, assessing the situation in the Middle East.
(RTTNews) - Canadian stocks are likely to open on a mixed note Friday morning with investors making cautious moves, assessing the situation in the Middle East.